Cytek Biosciences, Inc. (CTKB) earnings
CTKB earnings moved a median of +1.34% by the close. Quarterly and annual CTKB reports and results, each read against the price at its own news timestamp. Back to the CTKB overview →
31 measured CTKB earnings events.
Where these CTKB earnings landedvs 31 measured CTKB earnings reactions
| Middle 50% of CTKB earnings reactions | -3.60% to +4.78% |
|---|---|
| Median reaction (to close) | +1.34% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 CTKB earnings events with a measured close landed between -3.60% and +4.78%; 61% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cytek Biosciences Reports Second Quarter 2026 Financial Results | Press release | -4.35% | -4.80% | |
| Form 10-Q Cytek Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.35% | -4.80% | |
| Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026 | Press release | +3.91% | +1.79% | |
| Cytek Biosciences Reports First Quarter 2026 Financial Results | Press release | +6.68% | +2.67% | |
| Form 10-Q Cytek Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +6.68% | +2.67% | |
| Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | +0.82% | +3.53% | |
| Form 10-K Cytek Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.09% | +5.16% | |
| Cytek Biosciences Reports Third Quarter 2025 Financial Results | Press release | +3.04% | +6.32% | |
| Form 10-Q Cytek Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.04% | +6.32% | |
| Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 | Press release | +0.48% | +0.97% | |
| Cytek Biosciences Reports Second Quarter 2025 Financial Results | Press release | +1.64% | +5.66% | |
| Form 10-Q Cytek Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.64% | +5.66% | |
| Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025 | Press release | -1.20% | -0.30% | |
| Cytek Biosciences Reports First Quarter 2025 Financial Results | Press release | +6.77% | -5.64% | |
| Form 10-Q Cytek Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +6.77% | -5.64% | |
| Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | +1.20% | +0.53% | |
| Form 10-K Cytek Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.83% | -2.39% | |
| Form 10-Q Cytek Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.08% | -5.37% | |
| Cytek Biosciences Reports Third Quarter 2024 Financial Results | Press release | +12.88% | +23.75% | |
| Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024 | Press release | +1.68% | +2.73% | |
| Cytek Biosciences Reports Second Quarter 2024 Financial Results | Press release | -6.84% | -10.70% | |
| Form 10-Q Cytek Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | -6.84% | -10.70% | |
| Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024 | Press release | +1.06% | +1.21% | |
| Cytek Biosciences Reports First Quarter 2024 Financial Results | Press release | +1.57% | -2.36% | |
| Form 10-Q Cytek Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.57% | -2.36% | |
| Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024 | Press release | +1.62% | +2.73% | |
| Form 10-K Cytek Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.34% | +1.34% | |
| Form NT 10-K Cytek Biosciences, Inc. For: Dec 31 | SEC filing · Form NT | -3.53% | -8.04% | |
| Form 10-Q Cytek Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.55% | +4.39% | |
| Form NT 10-Q Cytek Biosciences, Inc. For: Sep 30 | SEC filing · Form NT | +1.76% | +6.84% | |
| Cytek Biosciences Reports Third Quarter 2023 Financial Results | Press release | +11.05% | +31.58% |
Keep exploring
More CTKB: analyst actions → · SEC filings → · CTKB overview →